Roth Capital Adds PPHM as Top Biotech & Says PPHM Poised for Furthur Upside" read post.
Bio Tuesdays Updated September 9, 2012
Roth adds Peregrine to Focus List
by stephenkilmer · Leave a Comment
Roth Capital Partners has added Peregrine Pharmaceuticals (NASDAQ:PPHM) to its “Focus List as a top biotech pick,” saying it believes the stock is poised for further upside.